Advertisement

Topics

Latest "Damon Runyon Cancer Research Foundation" News Stories

05:24 EDT 19th October 2018 | BioPortfolio

Here are the most relevant search results for "Damon Runyon Cancer Research Foundation" found in our extensive news archives from over 250 global news sources.

More Information about Damon Runyon Cancer Research Foundation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Damon Runyon Cancer Research Foundation for you to read. Along with our medical data and news we also list Damon Runyon Cancer Research Foundation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Damon Runyon Cancer Research Foundation Companies for you to search.

Showing "Damon Runyon Cancer Research Foundation" News Articles 1–25 of 43,000+

Friday 19th October 2018

Statin reduces the risk of dementia in diabetic patients receiving androgen deprivation therapy for prostate cancer


Haem iron intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

OncoSil Medical Ltd OSL Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummaryOncoSil Medical Ltd OncoSil, formerly NeuroDiscovery Ltd is a medical device company that develops and commercializes treatments for patients with pancreatic and liver cancer. The company's lead product include oncosil, a brachytherapy device that emits beta radiation and is implanted directly inside the cancerous tumor during an endoscopic ultrasound guidance procedure. It offers various t...


Acura Pharmaceuticals Inc ACUR Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryAcura Pharmaceuticals Inc Acura is a specialty pharmaceutical company that researches, develops, and commercializes tamperresistant products to prevent the abuse and misuse of medication. The company's proprietary technologies, Aversion, Limitx and Impede, are used to prevent product tampering associated with opioid abuse. Its Impede technology helps minimize the extraction and conversion o...

NICE rejects Elil Lilly's Verzenio for breast cancer in draft guidance

Eli Lilly and patients with breast cancer patients in the UK have been dealt a blow as NICE confirmed that it has decided not to recommend the drugmaker’s therapy Verzenio (abemaciclib) for use on the NHS. The organisation’s draft guidance judged that the drug demonstrated efficacy on par with Pfizer’s Ibrance (palbociclib) and Novartis’ Kisqali (ribociclib) as a treatment for hormone rece...

Ginolis Oy Medical Equipment Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryGinolis Oy Ginolis is a provider of assembly automation and liquid handling solutions. The company offers extensive range of solutions based on its modular automation platforms. It manufacturers customized solutions for the automated processing and assembly of micro components. Ginolis' solutions include high precision, modularity and the ability to handle fluids in nanoscale. The company a...

Chemotherapy Induced Peripheral Neuropathy Pipeline Review, H2 2018 [Report Updated: 21082018] Prices from USD $2000

Chemotherapy Induced Peripheral Neuropathy Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Peripheral Neuropathy Pipeline Review, H2 2018, provides an overview of the Chemotherapy Induced Peripheral Neuropathy Toxicology pipeline landscape.Chemotherapyinduced peripheral neuropathy CIPN is a side effect of can...

Oncolys BioPharma Inc 4588 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27082018] Prices from USD $250

SummaryOncolys BioPharma Inc Oncolys is a biotechnology company that discovers and develops treatments for cancer and infectious diseases. The company import and export products including drugs and medicines, oncolytic viruses, pharmaceutical pipeline products and tumor diagnostic agents, among others. Its pharmaceutical pipeline products include OBP301, OBPAI001, OBP801, OBP601, and OBPAI002, amo...

Corium International Inc CORI Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27082018] Prices from USD $250

SummaryCorium International Inc Corium is a commercialstage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products include Corplex Memantine and Corplex Donepezil for the treatment of Alzheimer's disease. Corium also dev...

BTK: a two-faced effector in cancer and tumour suppression

Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer

YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect

WNDM Medical Inc WNDM Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24072018] Prices from USD $250

SummaryWNDM Medical Inc WNDM Medical, formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone bleeding. Its product finds application in all except third degree burns, acute wounds, and chronic wounds....

Shuttle Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryShuttle Pharmaceuticals Inc Shuttle, formerly Shuttle Pharmaceuticals LLC is a developer of therapies that offers novel drugs for improving cancer treatment outcomes. The company's pipeline products comprise therapies such as SP2001, SP1161, SP1003 and SP3001. Its therapies are used to improve the outcomes of patients receiving radiation therapy for the treatment of various types of cancers...

EMD Serono Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryEMD Serono Inc EMD, formerly Serono Inc, a subsidiary of Merck KGaA is a healthcare products provider that offers oncology products. The company offers neurology and immunology; metabolic endocrinology, fertility and oncology products. It offers neurology and immunology products to find new treatment options for drugs and combines approaches that target T and Bcell biology; cytokines and ch...

Biotechnology in Japan [Report Updated: 06062018] Prices from USD $350

Biotechnology in JapanSummaryBiotechnology in Japan industry profile provides topline qualitative and quantitative summary information including: market size value 201317, and forecast to 2022. The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.SynopsisEssential resource for topline data and analysis...

Washington University School of Medicine Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryWashington University School of Medicine WUSTL, a subsidiary of University of Washington is a medical university that offers patient care, research, education services and neurology clinical trials. The university provides patient care services such as clinical, find a doctor, referring physicians and others. Its research program comprise post doctoral research opportunities, research labs,...

Chi-Med Starts China Trials of Syk Inhibitor in Acute Myeloid Leukemia Patients

Hutchison China MediTech (Chi-Med) has started a China Phase I trial of its novel spleen tyrosine kinase (Syk) inhibitor as a first line treatment in elderly patients with acute myeloid leukemia. The molecule, HMPL-523, will be administered in combination with an approved nucleoside metabolic inhibitor. In September, Chi-Med's lead drug, Elunate® (fruquintinib), was approved in China as a thir...

Singlera Reports Positive Results from Blood-based Diagnostic for Colorectal Cancer

Singlera Genomics, a San Diego-Shanghai diagnostics company, reported its ColonES blood-based colorectal cancer diagnostic showed high sensitivity and specificity in an early China test. In a 1,243 patient study, the ColonES device produced sensitivities of 93% for CRC and 88% for advanced adenomas, with a specificity of 99%. The device is aimed at early diagnosis. Its targeted next-gen sequencing...

Cancer Stem Cells (CSCs) Market 2018 – By Facilitate Decision Making on the Basis of Historic and Forecasts Data 2025 – Automotive Magazine

Automotive MagazineCancer Stem Cells (CSCs) Market 2018 – By Facilitate Decision Making on the Basis of Historic and Forecasts Data 2025Automotive MagazineThe report “Cancer Stem Cells (CSCs) Market By Type (CellSearch and Other Types) – Global Forecast to 2025”, issued by Crystal Market Research, the market has come across substantial development in the recent years and is projected to gr...

Sunflower pollen good for bees; has medicinal and protective effects – The Indian Wire

The Indian WireSunflower pollen good for bees; has medicinal and protective effectsThe Indian WireIt has been worrying at how fast the bee populations are declining all over the globe, but a new study offers a glimmer of hope. The study suggests that for promoting bee health and well-being, bees should be given more access to sunflowers. The study ...Mitch Matters: honey bees' vital role in Mornin...

October 19 Research Roundup: Dementia, Frankenstein Proteins, and Epigenetic Sperm Changes http://dlvr.it/QnpBsg pic.twitter.com/Fh9xNPgMrt

October 19 Research Roundup: Dementia, Frankenstein Proteins, and Epigenetic Sperm Changes http://dlvr.it/QnpBsg  pic.twitter.com/Fh9xNPgMrt

Ward MM and Endocanna Health Announce Partnership Supporting Medicinal Cannabis Clinical Trials

MELBOURNE, Australia, Oct. 19, 2018 /PRNewswire/ -- Ward MM, (Melbourne, Australia) and Endocanna Health (Los Angeles, CA) are partnering to support Medicinal Cannabis trials and related research in Australia. Both companies share a common vision and goal in reducing medication-related harm and believe innovations in Medicinal Cannabis play an important role in providing the...

Meridian Bioscience Inc VIVO Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryMeridian Bioscience Inc Meridian is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for viral, gastrointestinal, respiratory and parasitic infectious disease indications. It also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufa...

Kareo Inc Medical Equipment Deals and Alliances Profile [Report Updated: 12092018] Prices from USD $250

SummaryKareo Inc Kareo provides a cloudbased medical technology platform that meets the needs of healthcare providers. The company offers cloudbased electronic health records EHR that helps clinicians to manage the care of the patients and record or access required information at the point of care. It also engaged in the medical billing services, is cloudbased billing module that enables healthcar...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks